Zhejiang Rongyao Biotech Co., Ltd.

Zhejiang Rongyao Biotech Co., Ltd., founded in 1999 as Linhai Rongyao Feed Additive Factory, is strategically located in Taizhou Bay National Economic and Technological Development Zone-a national core hub for biomedicine with a complete industrial chain, convenient transportation, and strong policy support. After 27 years of strategic transformation, it has evolved into an innovation-driven pharmaceutical enterprise integrating R&D, manufacturing, and global sales, adhering to the core philosophy of "Innovation for Health, Integrity for Development. "

The company has achieved remarkable milestones in its development: Passing Veterinary Drug GMP Certification in 2005, US FDA audits six times since 2006, being recognized as a National High-Tech Enterprise in 2009, and renaming itself Zhejiang Rongyao Biotech Co., Ltd. In 2015 to reflect its focus on biotech and pharmaceuticals. It has also established a National Postdoctoral Workstation, Provincial Enterprise Research Institute, and won multiple science and technology awards, demonstrating its strong comprehensive strength.

Technological innovation is the core driving force. Rongyao Biotech invests over 8% of its annual operating income in R&D, with a 120-strong team of professionals including doctors, masters, and senior engineers. It cooperates with renowned universities like Zhejiang University and the Chinese Academy of Sciences, and owns over 50 national patents. Its R&D focuses on three core areas: Pharmaceutical APIs/intermediates (covering anti-infective, anti-tumor drugs), veterinary APIs/preparations (safe and eco-friendly), and one-stop CDMO services for global clients.

Manufacturing is well-established with two standardized GMP production bases covering 100, 000 square meters, adopting advanced green technologies like enzyme catalysis and microchannel reaction. It has an annual capacity of over 10, 000 tons of pharmaceutical APIs/intermediates and 5, 000 tons of veterinary products, with a strict quality control system ensuring compliance with Chinese, US, and European standards.

Rongyao Biotech has built a global sales network covering 50+ countries, with long-term cooperation with world-renowned pharmaceutical companies. It supplies high-quality APIs and intermediates to Pfizer, provides CDMO services and veterinary products to Lilly (a key Asia-Pacific supplier), and collaborates with Thermo Fisher on pharmaceutical intermediates and technical support. It also values domestic markets, offering personalized services and a complete after-sales system.

Committed to green development, it has passed ISO14001 certification, adopted eco-friendly processes, and realized resource recycling. It also prioritizes talent, with a complete introduction, training, and incentive mechanism, winning the title of Taizhou Advanced Staff Home.

Looking ahead, Rongyao Biotech will adhere to the strategy of "innovation-driven, quality-first, global layout, " deepen international cooperation, and strive to become a world-class biotech and pharmaceutical enterprise, contributing to global health.